Your shopping cart is currently empty

Meayamycin B ((+)-Meayamycin B) is a potent SF3B1 inhibitor that modulates pre-mRNA splicing to increase the expression of pro-apoptotic protein Mcl-1S and decrease Mcl-1L expression, without affecting the alternative splicing of Bcl-x. It synergizes with ABT-737 to induce apoptosis and demonstrates anticancer activity against non-small cell lung cancer.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Meayamycin B ((+)-Meayamycin B) is a potent SF3B1 inhibitor that modulates pre-mRNA splicing to increase the expression of pro-apoptotic protein Mcl-1S and decrease Mcl-1L expression, without affecting the alternative splicing of Bcl-x. It synergizes with ABT-737 to induce apoptosis and demonstrates anticancer activity against non-small cell lung cancer. |
| Synonyms | (+)-Meayamycin B |
| Molecular Weight | 576.73 |
| Formula | C31H48N2O8 |
| Cas No. | 1020210-12-1 |
| Smiles | O[C@H]1[C@]2(CO2)CC(C)(C)O[C@@H]1/C=C/C(=C/C[C@H]3[C@@H](C)C[C@@H](NC(/C=C\[C@@H](OC(=O)N4CCOCC4)C)=O)[C@@H](C)O3)/C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.